drugset / Trial / NCT00139217

NO Need to Ventilate: A Trial of Non-invasive Inhaled Nitric Oxide in Persistent Pulmonary Hypertension of the Newborn

NCT00139217 ↗

Completed 400 enrolled Emory University
RandomizedSingle-groupOpen-labelTreatment

Summary

The primary objective of the trial is to determine the feasibility and clinical safety and efficacy of non-invasive inhaled nitric oxide in infants with PPHN without significant pulmonary +-parenchymal disease who would normally receive inhaled nitric oxide only after placement of a tracheal tube and the institution of mechanical ventilation.

Timeline

Start
2005-08
Primary completion
2007-09
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Subject inhaled nitric oxide Unknown 10 ppm Intranasal
Subject inhaled nitric oxide Unknown 20 ppm Intranasal